Medical Care
Global Psoriasis Therapeutics Market Research Report 2025
- Sep 18, 25
- ID: 507513
- Pages: 80
- Figures: 71
- Views: 9
This report aims to provide a comprehensive presentation of the global market for Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Therapeutics.
The Psoriasis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriasis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.
Segment by Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
Segment by Application
Oral
Parenteral
Topical
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriasis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Psoriasis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriasis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Astellas Pharma Inc.
AstraZeneca plc
Boehringer Ingelheim GmbH
F. Hofffmann-La Roche
GlaxoSmithKline plc
Merck & Co., Inc.
Valeant Pharmaceuticals International, Inc.
Biocon Limited
Eli Lilly and Company
G & W Laboratories Inc.
Segment by Type
TNF Inhibitors
PDE4 Inhibitors
Interleukin Blockers
Others
Segment by Application
Oral
Parenteral
Topical
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Psoriasis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriasis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2020-2031)
2.2 Global Psoriasis Therapeutics Growth Trends by Region
2.2.1 Global Psoriasis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriasis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Psoriasis Therapeutics Market Dynamics
2.3.1 Psoriasis Therapeutics Industry Trends
2.3.2 Psoriasis Therapeutics Market Drivers
2.3.3 Psoriasis Therapeutics Market Challenges
2.3.4 Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriasis Therapeutics Revenue
3.4 Global Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2024
3.5 Global Key Players of Psoriasis Therapeutics Head office and Area Served
3.6 Global Key Players of Psoriasis Therapeutics, Product and Application
3.7 Global Key Players of Psoriasis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2026-2031)
5 Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriasis Therapeutics Market Size (2020-2031)
6.2 North America Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriasis Therapeutics Market Size by Country (2020-2025)
6.4 North America Psoriasis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2020-2031)
7.2 Europe Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriasis Therapeutics Market Size by Country (2020-2025)
7.4 Europe Psoriasis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Psoriasis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriasis Therapeutics Market Size (2020-2031)
9.2 Latin America Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriasis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Psoriasis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.1.5 Astellas Pharma Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2020-2025)
11.2.5 AstraZeneca plc Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2020-2025)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Details
11.4.2 F. Hofffmann-La Roche Business Overview
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2020-2025)
11.4.5 F. Hofffmann-La Roche Recent Development
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Details
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2020-2025)
11.5.5 GlaxoSmithKline plc Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Details
11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
11.8 Biocon Limited
11.8.1 Biocon Limited Company Details
11.8.2 Biocon Limited Business Overview
11.8.3 Biocon Limited Psoriasis Therapeutics Introduction
11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2020-2025)
11.8.5 Biocon Limited Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2020-2025)
11.9.5 Eli Lilly and Company Recent Development
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Details
11.10.2 G & W Laboratories Inc. Business Overview
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.10.5 G & W Laboratories Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 TNF Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Interleukin Blockers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psoriasis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Oral
1.3.3 Parenteral
1.3.4 Topical
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Psoriasis Therapeutics Market Perspective (2020-2031)
2.2 Global Psoriasis Therapeutics Growth Trends by Region
2.2.1 Global Psoriasis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Psoriasis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Psoriasis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Psoriasis Therapeutics Market Dynamics
2.3.1 Psoriasis Therapeutics Industry Trends
2.3.2 Psoriasis Therapeutics Market Drivers
2.3.3 Psoriasis Therapeutics Market Challenges
2.3.4 Psoriasis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Psoriasis Therapeutics Players by Revenue
3.1.1 Global Top Psoriasis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Psoriasis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Psoriasis Therapeutics Revenue
3.4 Global Psoriasis Therapeutics Market Concentration Ratio
3.4.1 Global Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psoriasis Therapeutics Revenue in 2024
3.5 Global Key Players of Psoriasis Therapeutics Head office and Area Served
3.6 Global Key Players of Psoriasis Therapeutics, Product and Application
3.7 Global Key Players of Psoriasis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Psoriasis Therapeutics Breakdown Data by Type
4.1 Global Psoriasis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Psoriasis Therapeutics Forecasted Market Size by Type (2026-2031)
5 Psoriasis Therapeutics Breakdown Data by Application
5.1 Global Psoriasis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Psoriasis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Psoriasis Therapeutics Market Size (2020-2031)
6.2 North America Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Psoriasis Therapeutics Market Size by Country (2020-2025)
6.4 North America Psoriasis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Psoriasis Therapeutics Market Size (2020-2031)
7.2 Europe Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Psoriasis Therapeutics Market Size by Country (2020-2025)
7.4 Europe Psoriasis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Psoriasis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Psoriasis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Psoriasis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Psoriasis Therapeutics Market Size (2020-2031)
9.2 Latin America Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Psoriasis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Psoriasis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Psoriasis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Psoriasis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Astellas Pharma Inc.
11.1.1 Astellas Pharma Inc. Company Details
11.1.2 Astellas Pharma Inc. Business Overview
11.1.3 Astellas Pharma Inc. Psoriasis Therapeutics Introduction
11.1.4 Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.1.5 Astellas Pharma Inc. Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Psoriasis Therapeutics Introduction
11.2.4 AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2020-2025)
11.2.5 AstraZeneca plc Recent Development
11.3 Boehringer Ingelheim GmbH
11.3.1 Boehringer Ingelheim GmbH Company Details
11.3.2 Boehringer Ingelheim GmbH Business Overview
11.3.3 Boehringer Ingelheim GmbH Psoriasis Therapeutics Introduction
11.3.4 Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2020-2025)
11.3.5 Boehringer Ingelheim GmbH Recent Development
11.4 F. Hofffmann-La Roche
11.4.1 F. Hofffmann-La Roche Company Details
11.4.2 F. Hofffmann-La Roche Business Overview
11.4.3 F. Hofffmann-La Roche Psoriasis Therapeutics Introduction
11.4.4 F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2020-2025)
11.4.5 F. Hofffmann-La Roche Recent Development
11.5 GlaxoSmithKline plc
11.5.1 GlaxoSmithKline plc Company Details
11.5.2 GlaxoSmithKline plc Business Overview
11.5.3 GlaxoSmithKline plc Psoriasis Therapeutics Introduction
11.5.4 GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2020-2025)
11.5.5 GlaxoSmithKline plc Recent Development
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Details
11.6.2 Merck & Co., Inc. Business Overview
11.6.3 Merck & Co., Inc. Psoriasis Therapeutics Introduction
11.6.4 Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.6.5 Merck & Co., Inc. Recent Development
11.7 Valeant Pharmaceuticals International, Inc.
11.7.1 Valeant Pharmaceuticals International, Inc. Company Details
11.7.2 Valeant Pharmaceuticals International, Inc. Business Overview
11.7.3 Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Introduction
11.7.4 Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.7.5 Valeant Pharmaceuticals International, Inc. Recent Development
11.8 Biocon Limited
11.8.1 Biocon Limited Company Details
11.8.2 Biocon Limited Business Overview
11.8.3 Biocon Limited Psoriasis Therapeutics Introduction
11.8.4 Biocon Limited Revenue in Psoriasis Therapeutics Business (2020-2025)
11.8.5 Biocon Limited Recent Development
11.9 Eli Lilly and Company
11.9.1 Eli Lilly and Company Company Details
11.9.2 Eli Lilly and Company Business Overview
11.9.3 Eli Lilly and Company Psoriasis Therapeutics Introduction
11.9.4 Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2020-2025)
11.9.5 Eli Lilly and Company Recent Development
11.10 G & W Laboratories Inc.
11.10.1 G & W Laboratories Inc. Company Details
11.10.2 G & W Laboratories Inc. Business Overview
11.10.3 G & W Laboratories Inc. Psoriasis Therapeutics Introduction
11.10.4 G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2020-2025)
11.10.5 G & W Laboratories Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of PDE4 Inhibitors
Table 4. Key Players of Interleukin Blockers
Table 5. Key Players of Others
Table 6. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Psoriasis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Psoriasis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Psoriasis Therapeutics Market Share by Region (2020-2025)
Table 10. Global Psoriasis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Psoriasis Therapeutics Market Share by Region (2026-2031)
Table 12. Psoriasis Therapeutics Market Trends
Table 13. Psoriasis Therapeutics Market Drivers
Table 14. Psoriasis Therapeutics Market Challenges
Table 15. Psoriasis Therapeutics Market Restraints
Table 16. Global Psoriasis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Psoriasis Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2024)
Table 19. Ranking of Global Top Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Psoriasis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Psoriasis Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Psoriasis Therapeutics, Product and Application
Table 23. Global Key Players of Psoriasis Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriasis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Psoriasis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Psoriasis Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Psoriasis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Psoriasis Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Psoriasis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Psoriasis Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Psoriasis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Astellas Pharma Inc. Company Details
Table 49. Astellas Pharma Inc. Business Overview
Table 50. Astellas Pharma Inc. Psoriasis Therapeutics Product
Table 51. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Astellas Pharma Inc. Recent Development
Table 53. AstraZeneca plc Company Details
Table 54. AstraZeneca plc Business Overview
Table 55. AstraZeneca plc Psoriasis Therapeutics Product
Table 56. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 57. AstraZeneca plc Recent Development
Table 58. Boehringer Ingelheim GmbH Company Details
Table 59. Boehringer Ingelheim GmbH Business Overview
Table 60. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product
Table 61. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Boehringer Ingelheim GmbH Recent Development
Table 63. F. Hofffmann-La Roche Company Details
Table 64. F. Hofffmann-La Roche Business Overview
Table 65. F. Hofffmann-La Roche Psoriasis Therapeutics Product
Table 66. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 67. F. Hofffmann-La Roche Recent Development
Table 68. GlaxoSmithKline plc Company Details
Table 69. GlaxoSmithKline plc Business Overview
Table 70. GlaxoSmithKline plc Psoriasis Therapeutics Product
Table 71. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 72. GlaxoSmithKline plc Recent Development
Table 73. Merck & Co., Inc. Company Details
Table 74. Merck & Co., Inc. Business Overview
Table 75. Merck & Co., Inc. Psoriasis Therapeutics Product
Table 76. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Merck & Co., Inc. Recent Development
Table 78. Valeant Pharmaceuticals International, Inc. Company Details
Table 79. Valeant Pharmaceuticals International, Inc. Business Overview
Table 80. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product
Table 81. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Valeant Pharmaceuticals International, Inc. Recent Development
Table 83. Biocon Limited Company Details
Table 84. Biocon Limited Business Overview
Table 85. Biocon Limited Psoriasis Therapeutics Product
Table 86. Biocon Limited Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Biocon Limited Recent Development
Table 88. Eli Lilly and Company Company Details
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Psoriasis Therapeutics Product
Table 91. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Eli Lilly and Company Recent Development
Table 93. G & W Laboratories Inc. Company Details
Table 94. G & W Laboratories Inc. Business Overview
Table 95. G & W Laboratories Inc. Psoriasis Therapeutics Product
Table 96. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 97. G & W Laboratories Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Psoriasis Therapeutics Picture
Figure 2. Global Psoriasis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriasis Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. TNF Inhibitors Features
Figure 5. PDE4 Inhibitors Features
Figure 6. Interleukin Blockers Features
Figure 7. Others Features
Figure 8. Global Psoriasis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Psoriasis Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Oral Case Studies
Figure 11. Parenteral Case Studies
Figure 12. Topical Case Studies
Figure 13. Psoriasis Therapeutics Report Years Considered
Figure 14. Global Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Psoriasis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Psoriasis Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Psoriasis Therapeutics Market Share by Players in 2024
Figure 18. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2024
Figure 20. North America Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Psoriasis Therapeutics Market Share by Region (2020-2031)
Figure 34. China Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 50. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 51. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 52. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 53. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 54. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 55. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 56. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 58. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Table 1. Global Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of TNF Inhibitors
Table 3. Key Players of PDE4 Inhibitors
Table 4. Key Players of Interleukin Blockers
Table 5. Key Players of Others
Table 6. Global Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Psoriasis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Psoriasis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Psoriasis Therapeutics Market Share by Region (2020-2025)
Table 10. Global Psoriasis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Psoriasis Therapeutics Market Share by Region (2026-2031)
Table 12. Psoriasis Therapeutics Market Trends
Table 13. Psoriasis Therapeutics Market Drivers
Table 14. Psoriasis Therapeutics Market Challenges
Table 15. Psoriasis Therapeutics Market Restraints
Table 16. Global Psoriasis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Psoriasis Therapeutics Market Share by Players (2020-2025)
Table 18. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2024)
Table 19. Ranking of Global Top Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Psoriasis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Psoriasis Therapeutics, Headquarters and Area Served
Table 22. Global Key Players of Psoriasis Therapeutics, Product and Application
Table 23. Global Key Players of Psoriasis Therapeutics, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psoriasis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Psoriasis Therapeutics Revenue Market Share by Type (2020-2025)
Table 27. Global Psoriasis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Psoriasis Therapeutics Revenue Market Share by Type (2026-2031)
Table 29. Global Psoriasis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Psoriasis Therapeutics Revenue Market Share by Application (2020-2025)
Table 31. Global Psoriasis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Psoriasis Therapeutics Revenue Market Share by Application (2026-2031)
Table 33. North America Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Psoriasis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Psoriasis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 48. Astellas Pharma Inc. Company Details
Table 49. Astellas Pharma Inc. Business Overview
Table 50. Astellas Pharma Inc. Psoriasis Therapeutics Product
Table 51. Astellas Pharma Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 52. Astellas Pharma Inc. Recent Development
Table 53. AstraZeneca plc Company Details
Table 54. AstraZeneca plc Business Overview
Table 55. AstraZeneca plc Psoriasis Therapeutics Product
Table 56. AstraZeneca plc Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 57. AstraZeneca plc Recent Development
Table 58. Boehringer Ingelheim GmbH Company Details
Table 59. Boehringer Ingelheim GmbH Business Overview
Table 60. Boehringer Ingelheim GmbH Psoriasis Therapeutics Product
Table 61. Boehringer Ingelheim GmbH Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 62. Boehringer Ingelheim GmbH Recent Development
Table 63. F. Hofffmann-La Roche Company Details
Table 64. F. Hofffmann-La Roche Business Overview
Table 65. F. Hofffmann-La Roche Psoriasis Therapeutics Product
Table 66. F. Hofffmann-La Roche Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 67. F. Hofffmann-La Roche Recent Development
Table 68. GlaxoSmithKline plc Company Details
Table 69. GlaxoSmithKline plc Business Overview
Table 70. GlaxoSmithKline plc Psoriasis Therapeutics Product
Table 71. GlaxoSmithKline plc Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 72. GlaxoSmithKline plc Recent Development
Table 73. Merck & Co., Inc. Company Details
Table 74. Merck & Co., Inc. Business Overview
Table 75. Merck & Co., Inc. Psoriasis Therapeutics Product
Table 76. Merck & Co., Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 77. Merck & Co., Inc. Recent Development
Table 78. Valeant Pharmaceuticals International, Inc. Company Details
Table 79. Valeant Pharmaceuticals International, Inc. Business Overview
Table 80. Valeant Pharmaceuticals International, Inc. Psoriasis Therapeutics Product
Table 81. Valeant Pharmaceuticals International, Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 82. Valeant Pharmaceuticals International, Inc. Recent Development
Table 83. Biocon Limited Company Details
Table 84. Biocon Limited Business Overview
Table 85. Biocon Limited Psoriasis Therapeutics Product
Table 86. Biocon Limited Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 87. Biocon Limited Recent Development
Table 88. Eli Lilly and Company Company Details
Table 89. Eli Lilly and Company Business Overview
Table 90. Eli Lilly and Company Psoriasis Therapeutics Product
Table 91. Eli Lilly and Company Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 92. Eli Lilly and Company Recent Development
Table 93. G & W Laboratories Inc. Company Details
Table 94. G & W Laboratories Inc. Business Overview
Table 95. G & W Laboratories Inc. Psoriasis Therapeutics Product
Table 96. G & W Laboratories Inc. Revenue in Psoriasis Therapeutics Business (2020-2025) & (US$ Million)
Table 97. G & W Laboratories Inc. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
Table 101. Authors List of This Report
List of Figures
Figure 1. Psoriasis Therapeutics Picture
Figure 2. Global Psoriasis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Psoriasis Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. TNF Inhibitors Features
Figure 5. PDE4 Inhibitors Features
Figure 6. Interleukin Blockers Features
Figure 7. Others Features
Figure 8. Global Psoriasis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Psoriasis Therapeutics Market Share by Application: 2024 VS 2031
Figure 10. Oral Case Studies
Figure 11. Parenteral Case Studies
Figure 12. Topical Case Studies
Figure 13. Psoriasis Therapeutics Report Years Considered
Figure 14. Global Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Psoriasis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Psoriasis Therapeutics Market Share by Region: 2024 VS 2031
Figure 17. Global Psoriasis Therapeutics Market Share by Players in 2024
Figure 18. Global Top Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Therapeutics as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Psoriasis Therapeutics Revenue in 2024
Figure 20. North America Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 22. United States Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 26. Germany Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Psoriasis Therapeutics Market Share by Region (2020-2031)
Figure 34. China Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 42. Mexico Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Psoriasis Therapeutics Market Share by Country (2020-2031)
Figure 46. Turkey Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Astellas Pharma Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 50. AstraZeneca plc Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 51. Boehringer Ingelheim GmbH Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 52. F. Hofffmann-La Roche Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 53. GlaxoSmithKline plc Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 54. Merck & Co., Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 55. Valeant Pharmaceuticals International, Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 56. Biocon Limited Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 58. G & W Laboratories Inc. Revenue Growth Rate in Psoriasis Therapeutics Business (2020-2025)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232